(binhthuan.gov.vn)  The Drug Administration (Ministry of Health) has just issued an official dispatch to the Departments of Health of provinces and centrally governed cities regarding counterfeit Theophylline 200mg.

To ensure safety for users, the Drug Administration requests the Departments of Health of provinces and centrally governed cities, as well as health authorities of other sectors, to inform drug businesses and users about counterfeit medicines labeled as: Theophylline 200mg Tablets (Theophylin 200mg), manufactured by Pharmacy Laboratories Plus (Warszawa), with no information about the registration number and/or drug approval number on the label.

Following the direction of the Drug Administration (Ministry of Health), the Department of Health of Bình Thuận Province has issued an official dispatch requiring healthcare facilities, drug businesses, and users to refrain from selling, distributing, or using the batch of drugs labeled as: Theophylline 200mg Tablets (Theophylin 200mg), manufactured by Pharmacy Laboratories Plus (Warszawa), with no information about the registration number and/or drug approval number on the label. Pharmaceutical companies and district, town, and city health centers are also required to inform the units under their direct management to take action accordingly.

The Department of Health also requested the Provincial Center for Disease Control to cooperate with media agencies to inform the public to avoid using the counterfeit THEOPHYLLINE 200mg mentioned above; to only buy and sell medicines at licensed drug establishments; not to buy or sell medicines of unknown origin; and to promptly report any suspicious signs of counterfeit drugs or drugs of unclear origin to the Department of Health and relevant authorities.

The Drug, Cosmetics, and Food Testing Center should increase sample collection and quality testing of drugs circulating in the area, particularly those at risk of being counterfeit or of poor quality. The center must promptly report any detected cases to the Department of Health and relevant authorities.

The Department of Health's Inspectorate, upon receiving information or discovering counterfeit drug samples with the aforementioned labeling, must proactively and promptly report to the Provincial 389 Steering Committee and coordinate with relevant authorities to inspect drug businesses in the area, investigate and verify information, and trace the origin of the counterfeit THEOPHYLLINE 200mg. Strict actions should be taken against organizations and individuals violating current regulations. Futhermore, efforts should be made to promptly detect and prevent the production, sale, and use of counterfeit THEOPHYLLINE 200mg. The results of inspections and violation handling should be reported to the Drug Administration (if any).

The Department of Health has also announced a hotline (phone number 02523.830.670) to receive information about counterfeit drugs, smuggled drugs, and drugs of unknown origin in the province, in order to promptly collaborate with relevant authorities to verify and address the cases.

Hữu Tri